VISTAGEN THERAPEUTICS, INC. (VTGN)
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
RCI to File 10-Q and Host 3Q26 Conference Call on X Spaces at 4:30 PM ET Today
Inuvo’s IntentKey a Powerful Tool in Identifying Net-New Open Enrollment Customers
Onfolio Holdings Announces 1-For-50 Reverse Stock Split To Regain Nasdaq Compliance; Reducing Float To Approximately 850,000 Shares
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
PSQ Holdings Named Exclusive Payments and Consumer Credit Provider for Rayon AI's Cutting-Edge Second-Amendment Enablement Platform
Klarna Goes Live With J.P. Morgan Payments, Opening Flexible Checkout to U.S. Merchants
HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
Exzeo Group Launches Exzeo Ventures to Build the Next Generation of AI-Native Businesses